# TINAG suppresses renal cell carcinoma progression and angiogenesis by rebalancing mTORC1 signaling via integrin α3β1 receptor

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41419-026-09295-8) · 2026-11-10 · Life
Page: https://themorning.science/story/tinag-suppresses-renal-cell-carcinoma-progression-and-angiogenesis-by-rebalancin-5bb206ff864086f0
Kind: research · Impact: medium

## In brief

- A study reports that TINAG suppresses renal cell carcinoma progression and angiogenesis.
- According to the study title, TINAG rebalances mTORC1 signalling via the integrin α3β1 receptor.

## Why it matters

It describes a specific molecular pathway involved in renal cell carcinoma progression, which cancer researchers may use to guide further study of mTORC1 and integrin signalling.

## Timeline

- 2026-11-10: Study listed in Nature subject feed

## Coverage

- [TINAG suppresses renal cell carcinoma progression and angiogenesis by rebalancing mTORC1 signaling via integrin α3β1 receptor](https://www.nature.com/articles/s41419-026-09295-8) — Biological sciences : nature.com subject feeds, 2026-11-10

Tags: renal cell carcinoma, tinag, mtorc1, angiogenesis, integrin

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science